Capital Advantage, Inc.
- SEC CIK
- 0001628896
- Latest filing
- Jul 13, 2026
NVS holding history
Novartis AG in every 13F filed by Capital Advantage, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q2 2026)
- 0
- Sold out in Q2 2026
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 4
- Since Q2 2025
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 0 | $0 | 0.0% | −1,846−100.0% | Sold out | Holders |
| Q1 2026 | 1,846 | $282.0K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 1,846 | $254.5K | <0.1% | +89+5.1% | Added | Holders |
| Q3 2025 | 1,757 | $225.3K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 1,757 | $212.6K | <0.1% | +1,757 | New | Holders |